Cargando…

Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1

BACKGROUND: Plexiform neurofibroma (PNF) in the porta hepatis (PH) is an unusual manifestation of neurofibromatosis-1 (NF-1). Resection is often recommended given the risk of malignant transformation. We encountered a challenging case in clinical practice which prompted us to report our findings and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yepuri, Natesh, Naous, Rana, Richards, Camille, Kittur, Dilip, Jain, Ajay, Dhir, Mashaal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925028/
https://www.ncbi.nlm.nih.gov/pubmed/29849532
http://dx.doi.org/10.1155/2018/7814763
_version_ 1783318633051586560
author Yepuri, Natesh
Naous, Rana
Richards, Camille
Kittur, Dilip
Jain, Ajay
Dhir, Mashaal
author_facet Yepuri, Natesh
Naous, Rana
Richards, Camille
Kittur, Dilip
Jain, Ajay
Dhir, Mashaal
author_sort Yepuri, Natesh
collection PubMed
description BACKGROUND: Plexiform neurofibroma (PNF) in the porta hepatis (PH) is an unusual manifestation of neurofibromatosis-1 (NF-1). Resection is often recommended given the risk of malignant transformation. We encountered a challenging case in clinical practice which prompted us to report our findings and perform a systematic review on the management of these tumors. METHODS: We reported the case of a 31-year-old woman with NF-1 and PNF of the PH. PRISMA 2009 guidelines were followed for systematic review. RESULTS: Our patient was found to have unresectable disease at exploration. After >5 years of follow-up, she continued to have stable disease on imaging. We identified 12 studies/case reports including 10 adult and 6 pediatric patients with PNF of PH. None of the 7 adult patients with NF-1 and PNF of PH underwent a successful tumor resection. All pediatric patients were managed with surveillance alone. All but one pediatric patient had NF-1. None of the reported cases of PNF of PH had malignant transformation. CONCLUSION: Our findings suggest that PNFs of PH in the setting of NF-1 are often unresectable and may have an indolent course. Surveillance alone may be a reasonable option in some patients; however, further studies are needed.
format Online
Article
Text
id pubmed-5925028
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59250282018-05-30 Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1 Yepuri, Natesh Naous, Rana Richards, Camille Kittur, Dilip Jain, Ajay Dhir, Mashaal HPB Surg Research Article BACKGROUND: Plexiform neurofibroma (PNF) in the porta hepatis (PH) is an unusual manifestation of neurofibromatosis-1 (NF-1). Resection is often recommended given the risk of malignant transformation. We encountered a challenging case in clinical practice which prompted us to report our findings and perform a systematic review on the management of these tumors. METHODS: We reported the case of a 31-year-old woman with NF-1 and PNF of the PH. PRISMA 2009 guidelines were followed for systematic review. RESULTS: Our patient was found to have unresectable disease at exploration. After >5 years of follow-up, she continued to have stable disease on imaging. We identified 12 studies/case reports including 10 adult and 6 pediatric patients with PNF of PH. None of the 7 adult patients with NF-1 and PNF of PH underwent a successful tumor resection. All pediatric patients were managed with surveillance alone. All but one pediatric patient had NF-1. None of the reported cases of PNF of PH had malignant transformation. CONCLUSION: Our findings suggest that PNFs of PH in the setting of NF-1 are often unresectable and may have an indolent course. Surveillance alone may be a reasonable option in some patients; however, further studies are needed. Hindawi 2018-04-15 /pmc/articles/PMC5925028/ /pubmed/29849532 http://dx.doi.org/10.1155/2018/7814763 Text en Copyright © 2018 Natesh Yepuri et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yepuri, Natesh
Naous, Rana
Richards, Camille
Kittur, Dilip
Jain, Ajay
Dhir, Mashaal
Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1
title Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1
title_full Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1
title_fullStr Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1
title_full_unstemmed Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1
title_short Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1
title_sort nonoperative management may be a viable approach to plexiform neurofibroma of the porta hepatis in patients with neurofibromatosis-1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925028/
https://www.ncbi.nlm.nih.gov/pubmed/29849532
http://dx.doi.org/10.1155/2018/7814763
work_keys_str_mv AT yepurinatesh nonoperativemanagementmaybeaviableapproachtoplexiformneurofibromaoftheportahepatisinpatientswithneurofibromatosis1
AT naousrana nonoperativemanagementmaybeaviableapproachtoplexiformneurofibromaoftheportahepatisinpatientswithneurofibromatosis1
AT richardscamille nonoperativemanagementmaybeaviableapproachtoplexiformneurofibromaoftheportahepatisinpatientswithneurofibromatosis1
AT kitturdilip nonoperativemanagementmaybeaviableapproachtoplexiformneurofibromaoftheportahepatisinpatientswithneurofibromatosis1
AT jainajay nonoperativemanagementmaybeaviableapproachtoplexiformneurofibromaoftheportahepatisinpatientswithneurofibromatosis1
AT dhirmashaal nonoperativemanagementmaybeaviableapproachtoplexiformneurofibromaoftheportahepatisinpatientswithneurofibromatosis1